BIOCHEMICAL
Vol. 181, No. 2, 1991 December
AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 579-584
16, 1991
Structural
Properties Satish
of Human Carbonic Anhydrase K. Nair and David
II at pH 9.5
W. Christianson*
Department of Chemistry University of Pennsylvania Philadelphia, Pennsylvania 191046323
Received
October
3, 1991
The structure of human carbonic anhydrase II at pH 9.5 has been studied by X-ray crystallographic methods to 2.2 di resolution. These studies complement those pecformed under acidic conditions in which the catalytically-important proton-shuttle group, His-64, exhibits conformational mobility about side-chain torsion angle xi. However, no structural changes are observed in the conformation of His-64 at high pH. Therefore, we conclude that the protonation of His-64 (as well as zinc-bound hydroxide) may be a factor which contributes to the predominantly “out” conformation for His-64 observed at low pH. 0 1991 Academic Press, Inc.
The (CAD)
crystal
reveals
structure
a roughly-spherical
a catalytically-required
three histidine
residues
solvent
In addition
in the function
hydroxide
for His-64.
structure
surrounding
(i.e. rotations
the Thr-2OO+Ser
mutant
by 104” about
substitution
*
His-96 and His-119),
polyhedron.
crystallographic
mobility
ring-flipping
tates,
At physiological
anhydrase of which
oc-
pH, zinc is coordinated
by
and hydroxide
His-64,
(about
8 A away) through
studies
of CA11 indicate
resides
COs hydration
ion completes
to the zinc ligands,
of CAD
II
another
a
active
a catalytic
proton
shuttle,
a hydrogen
bonded
solvent
(3, 4). X-ray
tional
control.
(His-94,
is implicated
engages zinc-bound network
carbonic
active site cavity, at the bottom
of diffusion
coordination
site histidine
human
zinc ion (1, 2): it is here that catalytic
curs near the limit
tetrahedral
of the metalloenzyme
xi,
at position
To whom correspondence
In the native
structure
His-64 is consistent about of CAII
200 (5).
at pH 8.0 reveals
should
I n addition,
of blood
with
side chain torsion
as a compensatory
a high
response
degree CAII
of conformaat pH 8.5, the
an interpretation angle xZ) (2). that
of imidazole The structure
the His-64
to the conservative
structures
of
side chain amino
of CA11 determined
roacid
under
be addressed. 0006-291x/91 579
All
$1.50
Copyright 0 1991 by Academic Press, Inc. rights of reproduction in any form reserved.
Vol.
181, No. 2, 1991
acidic
conditions
by differences xr in order
BIOCHEMICAL
show that
His-64
(7), a detailed
a range of conformations
characterized
angle xi
values (6).
rotates
the binding
understanding
will assist rational In order
of factors
the structure
to a resolution
Since His-64
of thienothiopyran-2-sulfonamide which
influence
behavior
observed
Materials
and
in the enzyme
is fully active
mobility
of glaucoma
under
of CA11 at pH 9.5 by X-ray
of 2.2 A. The enzyme
differences
of His-64
about
inhibitors
t,his conformational
drug design efforts aimed at the treatment to assess the dynamic
have determined
RESEARCH COMMUNICATIONS
occupies
in side chain torsion
to accommodate
AND BIOPHYSlCAL
(8).
basic conditions,
crystallographic
we
methods
at pH 9.5 (9), so any structural
at this pH, if any, must sustain
catalysis.
Methods
harvested, and transHuman carbonic anhydrase II (S i g ma ) was crystallized, ferred to high-pa buffer in a procedure described previously (6, 10). Crystals sitting in a buffer droplet of 1.75 - 2.5 M (NH4)rS04, 3 mM NaNs, 150 mM NaCl, aminomethane hydrochloride), pH 8.0 were 50 mM Tris-HCl (Tris[hydroxymethyl]equilibrated against a buffer solution of 1.75-2.5 M (NH4)rS04, 50 mM CAPS0 j3[Cyclohexylaminol-2-hydroxy-1-propane-sulfonic acid), pH 9.5. The final pH of the buffer droplet in which each crystal was immersed was determined to be 9.5 f 0.2 using high-sensitivity pH paper from ColorpHast (EM Science). All X-ray diffraction data were collected at room temperature X-1OOA multiwire area detector mounted on a Rigaku RU-200 rotating generator. Raw data frames were analyzed using the BUDDHA (11) merged using the software PROTEIN (12). R e 1evant data collection found in Table I.
on a Siemens anode X-ray package and statistics are
The structure of the enzyme at pH 9.5 was refined against structure factors calculated from the refined structure of CAII at pH 8.5 (2) less the atomic coordinates of His-64 and active site water molecules. Model building was performed with the PS390. Crystalgraphics software FRODO (13) installed on an Evans and Sutherland lographic refinement utilized the reciprocal space least-squares algorithm of Konnert for Hisand Hendrickson, PROLSQ (14). A c t ive site water molecules and coordinates 64 were added when the crystallographic R-factor dropped below 0.19. The R-factor for the final model was 0.18, and relevant refinement statistics are recorded in Table I. Coordinates have been deposited in the Brookhaven Protein Data Bank (15).
Results
and
Discussion
The three-dimensional by Eriksson
and colleagues
nates (using
the software
A between culated
CAII
structure
of CA11 at pH 9.5 is similar
at pH 8.5 (2). Least squares superposition INSIGHT
pH 9.5 and 8.5 CAIIs.
for pH 9.5 CAII
the overall
structure
(Biosym,
Inc.))
yields
does not exhibit
basic conditions. 580
derived significant
of Ca coordi-
an rms difference
Given the rms coordinate
from relationships
to that reported
by Luzzati
error
of ca. 0.2 A cal-
(16), it appears
pH-dependent
of 0.2
variation
that under
Vol.
BIOCHEMICAL
181, No. 2, 1991
AND BIOPHYSICAL
Table Data Collection
RESEARCH COMMUNICATIONS
I
and Refinement
Statistics
for
CAD at pH 9.5 2
Number of crystals Number of measured reflections Number of unique reflections Maximum resolution (A) b,(W Number of water molecules in final cycle of refinement R factorb RMS deviation from ideal bond lengths (At RMS deviation from ideal bond angles (degrees) RMS deviation from ideal planarity (A) RMS deviation from ideal cbirality (As)
28,781 10,632 2.2 0.091 110 0.180 0.007 2.0 0.011 0.093
a Rmerge for replicate reflections, R = ~llF~~l~l~~ IF/J = scaled structure factor for reflection h in data set i. = average structure factor for reflection h from replicate data. b Crystallographic R factor, R = ZlIF,I - lFcII/EIF,,I; lFol and IFJ are the observed and calculated structure factors, respectively.
The imidazole this higher density,
side chain
pH and remains
interpretable
determined
Although
“out”
conformer The
position
coordination
which
and is an inhibitor to this ligand. non-protein
zinc-bound
and azide give
zinc ligand
remains
which
or instead
rise to the elongated
favorable
in the predominant
conformer
(Figure
the crystal density
density
1).
was soaked, corresponding
hydrogen
an exclusive
the
However,
corresponding
of disordered,
that equilibrium
occupied
at pH 8.5.
given the weaker
electron
the coordination
tions (6), are not evident
in which
However,
of
at pH 9.5, and
observed
a pair
as an azide anion.
(17); it is quite reasonable
have been observed
of this density
2, it is clear that the elongated as either
is reminiscent
a partially
(17), may affect the electron
to the bonded
interpretation
of
binding
of azide under
populations
of hydroxide
density.
polyhedron
over the pH range of 5.7 - 9.5 as observed Changes
Weak electron
at pH 6.5 (6) and pH 8.0
tetrahedral
is near that
at
of His-64 in structures
as solvent,
the appearance
in the buffer droplet
is interpretable
In conclusion,
conformer
this density
with
azide is not chemically
basic conditions
conformation.
maps calculated
polyhedron
is present
In Figure
molecules,
interpret
of the enzyme
ligand
an alternate
density
is not inconsistent
of the non-protein
azide anion,
water
electron
we tentatively
zinc
in the “in”
changes
lower pH values, persists at pH 9.5 (this density
in difference
(10).
His-64 shows no conformational
predominantly
as solvent and/or
at certain
that observed
of residue
of zinc in CA11 remains
in several crystallographic of His-64
in crystallographic under basic conditions: 581
in its “in”
studies
performed
His-64 remains
*
tetrahedral
investigations. “out”
under
equilibrium, acidic
predominantly
condiin the
Vol.
/
181, No. 2, 1991
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
/
>
Gi
Fidure 1. Difference electron density map of pH 9.5 CAD calculated with Fourier coefficients IF,,1 - lFcl and phases derived from the final model, less the atomic coordinates of His-64 and active site solvent molecules. The map is contoured at +2.3a (dashed lines), and refined atomic coordinates of pH 9.5 CA11 are superimposed (thick bonds): for comparison, the refined coordinates of pH 5.7 CA11 are also superimposed (thin bonds). Although a continuous trace of density places the imidazole group of His-64 in the “in” conformation, density interpretable as solvent (OHH 432) may instead represent a partial-occupancy “out” conformer of His-64; the “out” conformer is observed exclusively at pH 5.7.
Figure 2. Difference electron density map of pH 9.5 CA11 calculated with Fourier coefficients IF,1 - IF,1 and phases derived from the final model less the atomic coordinates of the non-protein zinc ligand. The map is contoured at $2.50, and refined atomic coordinates of pH 9.5 CA11 are superimposed. The non-protein zinc-ligand is characterized by elongated density and may reflect an equilibrium between ainchydroxide and zinc-azide species.
582
Vol.
181, No. 2, 1991
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
“in” conformation at pH 9.5. Therefore, we conclude that the protonation of His-64
[PK, = 7.1 (WI, as well aszinc-bound solvent [pK, = ca. 7.0 (19, 20)], may stabilize the “out” conformer of His-64 in X-ray crystallographic studies performed at lower pH values. Given that the “out” conformation of His-64 is observed in the Thr-2OO-+Ser mutant of CA11 at pH 8.0 (5)) a more general conclusion may be that the conformation of His-64 responds to structural changesin its environment: these changes may include protein, solvent, or counterion species. The structural implications of the His-64 conformational equilibrium will no doubt be important for understanding proton transfer in the CA11 active site (3, 4)) as well asfor the designof tight-binding enzyme inhibitors (7).
Acknowledgments
We thank the NSF for grant DIR-8821184 (in support of the X-ray data acquisition equipment) and the NIH for grant GM45614. Additionally, D.W.C. is grateful to the Office of Naval Researchfor a Young Investigator Award. S.K.N. is supported by N.I.H. Training Grant GM07229.
References
1. Liljas, A., Kannan, K.K., Bergsten, P.-C., Waara, I., Fridborg, K., Strandberg, B., Carlbom, U., Jarup, L., Lovgren, S., and Petef, M. (1972) Nature New Biol. 235, 131-137.
2. Eriksson, A.E., Jones, T.A., and Liljas A. (1988) Proteins: Gen.
Struct.
Funct.
4, 274-282.
3. Tu, C.K., Silverman, D.N., Forsman, C!., Jonsson, B.-H., and Lindskog, S. (1989) 28, 7913-7918.
Biochemistry
4. Silverman, D.N. and, Lindskog, S. (1988) Act.
Chem.
Res.
21, 30-36.
5. Krebs, J.F., Fierke, C.A., Alexander, R.S., and Christianson, D.W. (1991) Biochemistry 30, 9153-9160. 6. Nair, S.K. and Christianson, D.W. (1991) J. Am.
Chem.
Sot.,
in press.
7. Baldwin, J.J., Ponticello, G.S., Anderson, P.S., Christy, M.E., Murcko, M.A., Randall, W.C., Schwam, H., Sugrue, M.F., Springer, J.P., Gautheron, P., Grove, J., Mallorga, P., Viader, M.-P., McKeever, B.M., and Navia, M.A. (1989) J. Med. Chem. 32, 2510-2513. 8. Maren, T.H (1987) Drug.
Dev.
Res.
10, 255-276.
9. Lindskog, S. and Coleman, J.E. (1973) Proc. 2508.
Nat.
Acad.
Sci.
70, 2505-
10. Alexander, R.S., Nair, S.K., and Christianson, D.W. (1991) Biochemistry, in press. 11. Durbin, R.M., Burns, R., Moulai, J., Metcalf, P., Freymann, D., Blum, M., Anderson, J.E., Harrison, S.C., and Wiley, D.C. (1986) Science 232, 1127-1132. 12. Steigemann, W. (1974) Ph.D. th esis,Max Plank Institut fur Biochemie.
13. Jones, T.A. (1985) Methods
Enzymol.
583
115, 157-171.
Vol.
181, No. 2, 1991
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
14. Hendrickson, W.A., and Konnert, J.H. Conformation, Function and Evolution mon, Oxford, pp 43-47.
(1981) In Biomolecular (Srinivasan, R., Ed.).
Vol.
Structure, 1, Perga-
15. Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer, E.F., Brice, Rodgers, J.R., Kennard, O., Shimanouchi, T., and Tasumi, M. (1977) J. Mol.
M.D., Biol.
112, 535-542. 16. Luzzati,
P.V. (1952)
Acta
Cryst.
17. Tibell, L., Forsman, C., Simonsson, phys. Acta. 789, 302-310. 18. Campbell, 19. Davis, 20. Packer,
I.D., Lindskog,
R.P. (1958)
I., and Lindskog,
S., and White,
J. Am.
Y., and Meany,
5, 802-810.
Chem.
J.E. (1965)
Sot.
A.I. (1975)
J. Mol.
Biochim.
Biol.
80, 5209-5214.
Biochemistry
584
S. (1984)
11, 2535-2541.
Bi-
90, 597-614.